Faricimab in the Treatment of Exudative Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Italy: The FARIT Real World Study
Faricimab provided effective disease control and extended treatment intervals in treatment-naïve and previously treated eyes with nAMD and DME, showing a fast anatomical response and reduced injection burden.
Authors
- L M Bosch Del Marco
- Giulia Villa (ORCID: https://orcid.org/0000-0001-7429-0504)
- Emilia Sicari
- Vittorio Pirani (ORCID: https://orcid.org/0000-0001-5760-5607)
- Marco Lupidi (ORCID: https://orcid.org/0000-0002-6817-2488)
- Settimio Rossi (ORCID: https://orcid.org/0000-0002-8682-6860)
- Cristiana Iaculli (ORCID: https://orcid.org/0000-0003-0078-6480)
Institutions
- University of Foggia (IT)
- Marche Polytechnic University (IT)
- Roche (Italy) (IT)
- University of Campania "Luigi Vanvitelli" (IT)
- University of Macerata (IT)
Publication Details
- Journal
- Ophthalmology and Therapy
- Published
- 2025-07-19
- DOI
- https://doi.org/10.1007/s40123-025-01204-0
- Citations
- 2
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.41
Funders
- Roche Italia